Greenrose SPAC Announces Delisting on NASDAQ
NEW YORK–Cannabis-focused blank-check company Greenrose Acquisition Corp. has announced it plans on delisting its shares from the Nasdaq later this month, in anticipation of closing deals that would qualify it as a ”plant-touching” business in violation of the exchange’s rules.
The New York-based special purpose acquisition company, or SPAC, said in Thursday’s announcement that it has filed notice of its planned delisting with the Nasdaq and the U. S. Securities and Exchange Commission.
Latest News
Reunion Neuroscience to be Acquired by MPM BioImpact in $13.1 Million All-Cash Deal
LOS ANGELES-- Reunion Neuroscience Inc. a clinical-stage biopharmaceutical company specializing in innovative therapies for underserved mental health conditions, has announced a definitive arrangement agreement with MPM BioImpact, a leading biotechnology investment firm. Under the agreement, ...
California’s Regulated Cannabis Market Sees Decline in Sales and Tax Revenue in Q1 2023
LOS ANGELES-- California's hopes of increased consumer participation in the regulated cannabis market did not translate into a boost in licensed retail sales or state tax revenue during the first quarter of 2023. According to ...
C21 Investments Repays $30 Million Debt to CEO Sonny Newman
LOS ANGELES-- C21 Investments Inc., a vertically integrated cannabis company, announced today the successful completion of the full repayment of its $30 million senior secured note owed to Sonny Newman, the Company's President and Chief ...